Directly from the dpa news channel
SAN FRANCISCO (AFP) – The pharmaceutical and chemical company Bayer has to accept a setback in the US legal dispute over the cancer risk from the herbicide containing glyphosate, according to a report by Bloomberg Financial Agency. On Wednesday, Judge Vince Chhabria rejected the Leverkusen-based company’s request for interim approval to settle future disputes against payment of $ 2 billion (€ 1.6 billion good). Initially, no comments were received from Bayer. The proposal is part of a larger settlement related to the glyphosate issues.
Judge Chhabria was previously skeptical of a draft settlement to deal with future lawsuits related to glyphosate in the United States. The desired compromise for a total of $ 2 billion is now the crucial part of a more comprehensive settlement with plaintiffs, which would cost Bayer more than $ 11 billion in total, but which would put an end to the legal glyphosate disaster. In the court of Federal Judge Chhabria, many national proceedings were compiled.
© dpa-infocom, dpa: 210526-99-753608 / 2